Dolkar Tsering, Zouetr Michlene, Shankar Malavika, Rayapureddy Aditya Keerthi, Shiferaw-Deribe Zewge
Internal Medicine, One Brooklyn Health System Interfaith Medical Center, Brooklyn, USA.
Family Medicine, American Institute of Antigua College of Medicine, St John's, ATG.
Cureus. 2022 Jun 1;14(6):e25588. doi: 10.7759/cureus.25588. eCollection 2022 Jun.
Myxedema coma is a medical emergency with a high mortality rate. Patients with hypothyroidism may develop myxedema coma if left untreated, although quite rare nowadays owing to regular TSH (thyroid stimulating hormone) monitoring. We present the case of a patient with a known history of subclinical hypothyroidism, defined by normal free T4 (thyroxine) and high TSH, who was found to be in myxedema coma. Clinically, the patient was found to be lethargic, bradycardic, and hypothermic, and in the background of high TSH, myxedema coma was suspected. The patient was admitted to the ICU (Intensive Care Unit) and initially treated with intravenous (IV) hydrocortisone for possible concomitant adrenal insufficiency. This was followed by treatment with IV levothyroxine.
黏液性水肿昏迷是一种死亡率很高的医疗急症。甲状腺功能减退症患者若不治疗可能会发展为黏液性水肿昏迷,不过由于如今定期监测促甲状腺激素(TSH),这种情况相当罕见。我们报告一例已知患有亚临床甲状腺功能减退症的患者,其游离甲状腺素(T4)正常但TSH升高,该患者被发现处于黏液性水肿昏迷状态。临床上,患者表现为嗜睡、心动过缓和体温过低,鉴于TSH升高,怀疑为黏液性水肿昏迷。患者被收入重症监护病房(ICU),最初静脉注射氢化可的松以应对可能并存的肾上腺功能不全。随后给予静脉注射左甲状腺素进行治疗。